Universiti Kebangsaan Malaysia (UKM) through the Tissue Engineering and Regenerative Medicine Research Center, UKM Faculty of Medicine signed a Memorandum of agreement (MoA) with NK Biocell Sdn. Bhd., an agreement for production of MYJ1633 NK immune cell therapy. This MoA was signed by the Deputy Vice Chancellor (Research and Innovation), Prof. Dato’ Dr. Wan Kamal Mujani and Chief Executive Officer of NK Biocell Sdn. Bhd., Dr. Park Ji-Youn witnessed by UKM Faculty of Medicine Dean, Prof. Dr. Abdul Halim Abdul Ghafor and Medical Consultant NK Biocell Sdn. Bhd., Dr. Lan Leong Chung. Also present at this event was the Deputy Dean (Network and Alumni), UKM Faculty of Medicine, Prof. Dr. Marina Mat Baki.

Thank you to those who worked hard and made this event a success.